Keunchil Park

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

Keunchil Park

Mar 3, 2025, 15:56 | Science

Selpercatinib in RET Fusion-Positive NSCLC by Oliver Gautschi et al.

A paper by Oliver Gautschi et al. was published in the Journal of Clinical Oncology,…

Feb 25, 2025, 08:54 | Science

Diego Díaz García: Immunotherapy for advanced-stage SqNSCLC

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, shared a post on X…

May 18, 2024, 00:16 | Blog

Luis E. Raez: Analysis of PRO data from the landmark LIBRETTO-001 trial

Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on X: "In this…

All: 3 Posts: 1 - 100

'

Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy

'

Highlights from ELCC 2025

'

FDA Approved Pluvicto (177Lu-PSMA-617) for Metastatic Castration-Resistant Prostate Cancer

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023